DOW JONES21,413.44+469.93 2.24%
S&P 5002,526.90+56.40 2.28%
NASDAQ7,487.31+126.73 1.72%

H.C. Wainwright Initiates Coverage On Akero Therapeutics with Buy Rating, Announces $33 Price Target

H.C. Wainwright analyst Ed Arce initiates coverage on Akero Therapeutics (NASDAQ:AKRO) with a Buy rating and a $33 price target.

Benzinga · 03/02/2020 12:26

H.C. Wainwright analyst Ed Arce initiates coverage on Akero Therapeutics (NASDAQ:AKRO) with a Buy rating and a $33 price target.